BioLineRx Ltd.
BLRX
$2.55
-$0.04-1.54%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -38.36% | 145.88% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -38.36% | 145.88% | |||
| Cost of Revenue | -37.89% | 137.50% | |||
| Gross Profit | -38.48% | 148.05% | |||
| SG&A Expenses | 0.82% | -23.05% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 11.09% | -2.77% | |||
| Operating Income | -18.94% | 11.28% | |||
| Income Before Tax | -67.66% | -15.74% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -67.66% | -15.74% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 33.03% | 15.98% | |||
| Net Income | -89.01% | -15.60% | |||
| EBIT | -18.94% | 11.28% | |||
| EBITDA | -19.86% | 12.41% | |||
| EPS Basic | -83.33% | -20.00% | |||
| Normalized Basic EPS | -150.00% | 0.00% | |||
| EPS Diluted | -83.33% | -20.00% | |||
| Normalized Diluted EPS | -150.00% | 0.00% | |||
| Average Basic Shares Outstanding | 0.17% | -0.08% | |||
| Average Diluted Shares Outstanding | 0.17% | -0.08% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||